Medical aesthetics, or medical aesthetics for short, is a cosmetic method of repairing and reshaping a person's appearance and various parts of the human body using traumatic or irreversible medical techniques such as drugs, surgery, and medical devices. Next, let's take a look at the top ten leading stocks in the medical aesthetic industry: 1. Introduction: Medical aesthetic industry leader, the first domestic enterprise to obtain the registration certificate of the relevant products and medical devices. Products:Solution injection products, gel injection products, facial implants, cosmetics. Valuation:Total market capitalization of 123.67 billion, P/E ratio of 23.31, wow with TTM P/E ratio of 115.89, lower than the historical time 66%. Valuation is moderate. 2.Huaxi Biological Introduction: hyaluronic acid and other bioactive substances of the main products and biomedical materials of the end product. Products: hyaluronic acid raw materials (excluding derivatives), medical end products - injectable products, functional skin care products - disposable liquid. Valuation: Total market capitalization of 70.71 billion, P/E ratio of 11.64, TTM P/E ratio of 85.23, lower than the historical time 76%, valuation is low. 3.Aoyuan Meigu Introduction: China Plastic and Cosmetic Association certified 5A medical beauty institutions, the main business for the fiber new material business and medical beauty business. Products:Viscose series, real estate sales, medical beauty services. Valuation:Total market capitalization of 5.703 billion yuan, P/E ratio of 4.11, TTM P/E ratio is in the red, 27% lower than the historical time, valuation is high. 4.East China Medicine Introduction:Medical aesthetic industry focusing on facial fillers, body contouring, buried wire, energy device and other non-surgical mainstream medical aesthetic products. Products:Chinese and Western medicines, medical devices, differentiated sodium hyaluronate, collagen stimulant, A-type botulinum toxin, implantation line, energy devices. Valuation:Total market capitalization of $74.68 billion, P/E ratio of 4.3, TTM P/E ratio of 31.89, lower than the historical time 38%, valuation is moderate. 5.Hohai Health Department Introduction: A high-tech biomedical enterprise focusing on the research and development, production and sales of medical biomaterials. Products:Ophthalmic products, medical cosmetic and wound care products, anti-adhesion and hemostatic products. Valuation:Total market capitalization of 14.64 billion, P/E ratio of 2.63, TTM P/E ratio of 46.3, lower than the historical time 87%, valuation is low. 6. Ogilvy medical supplies company Introduction: medical dressings and other disposable medical supplies in the field of one of the few companies with a complete industrial chain. Products:The company's products cover wound care, surgery, infection prevention, medical combination packs, home care five series, some of the products are used in neurosurgery and other advanced areas. Valuation: total market capitalization of 7.726 billion, P/E ratio of 2.66, TTM P/E ratio of 16.35, lower than the historical time 87%, valuation is low. 7. Lancel Introduction:The company holds Milan Berylu, skin purification medical beauty, Gao Yisheng medical beauty three domestic medical brand, and strategic investment in South Korea's famous medical aesthetic services group DMG. Products:Women's coat, women's pants, women's skirts, women's coats, baby clothes, baby products, surgical medical beauty, non-surgical medical beauty, consulting services. Valuation:Total market capitalization of 13.34 billion, P/E ratio of 4.54, TTM P/E ratio of 128.99, 25% below the historical time, valuation is high. 8.Baofenix (woman's name) Profile:The company's subsidiary Kunming Weinuo is mainly engaged in medical cosmetic services, including laser, micro-needling and other beauty services. Products:Creams, skin care lotions, masks, essence, fierce reed wanton lotion and other skin care products, isolation cream, BB cream, makeup remover and other color cosmetics. Valuation:Total market capitalization of 78.11 billion, P/E ratio of 15.94, TTM P/E ratio of 83.96, lower than 90% of the historical time, valuation is extremely low. 9.Shui Yang shares Introduction: HPH is the company's new light medical beauty brand, currently mainly in Tmall, Ji Yun and other channels, the main body of the operation is Yu Jiahui Holdings. Products: Masks, water creams, color cosmetics, personal care, cleaning and other cosmetics. Valuation:Total market capitalization of 6.619 billion, P/E ratio of 3.9, TTM P/E ratio of 28.74, lower than 80% of the historical time, valuation is low. 10.Naturalization of Fang La Introduction:The company's main business is toiletries, skin care and color cosmetics products. Products:Creams, hair care branches sedan, body wash, shampoo, soap, gel water, gel cream Valuation:Total market capitalization 3.003 billion,